These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 4398415)

  • 1. Drugs and motor functions.
    Gordon N
    Dev Med Child Neurol; 1971 Jun; 13(3):384-6. PubMed ID: 4398415
    [No Abstract]   [Full Text] [Related]  

  • 2. [Specific therapy of extrapyramidal-motor syndromes].
    Hartmann-von Monakow K
    Bibl Psychiatr Neurol; 1969; 139():705-11. PubMed ID: 4257724
    [No Abstract]   [Full Text] [Related]  

  • 3. [Diseases of the extrapyramidal tracts--chorea, athetosis and others (excluding parkinsonism)].
    Watanabe H
    Naika; 1970 Jun; 25(6):1305-8. PubMed ID: 5431295
    [No Abstract]   [Full Text] [Related]  

  • 4. [l-dopa treatment of Parkinson's syndrome and mechanism of action of neuroleptics].
    Degkwitz R
    Med Klin; 1969 Aug; 64(33):1451-6. PubMed ID: 4896563
    [No Abstract]   [Full Text] [Related]  

  • 5. Tetrabenazine in the treatment of extrapyramidal dyskinesias.
    Gilligan BS; Wodak J; Veale JL; Munro OR
    Med J Aust; 1972 Nov; 2(19):1054-6. PubMed ID: 4264609
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of tetrabenazine on extrapyramidal movement disorders.
    Dalby MA
    Br Med J; 1969 May; 2(5654):422-3. PubMed ID: 4238453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experimental findings and new aspects in extrapyramidal diseases].
    Birkmayer W
    Wien Z Nervenheilkd Grenzgeb; 1966; 23(1):128-39. PubMed ID: 4226878
    [No Abstract]   [Full Text] [Related]  

  • 8. Dopamine and extrapyramidal motor function and dysfunction.
    Hornykiewicz O
    Res Publ Assoc Res Nerv Ment Dis; 1972; 50():390-415. PubMed ID: 4561070
    [No Abstract]   [Full Text] [Related]  

  • 9. [Neurochemical basis for pathological motor activity].
    Hole K
    Tidsskr Nor Laegeforen; 1974 Jan; 94(1):11-7. PubMed ID: 4362478
    [No Abstract]   [Full Text] [Related]  

  • 10. [Extrapyramidal syndrome in animal experiments: rôle of calcium and o-methylated derivatives].
    Radouco-Thomas S
    Laval Med; 1970 Sep; 41(7):886-93. PubMed ID: 5515480
    [No Abstract]   [Full Text] [Related]  

  • 11. Biochemical mechanisms and management of choreiform movement disorders.
    de Silva L
    Drugs; 1977 Oct; 14(4):300-10. PubMed ID: 144049
    [No Abstract]   [Full Text] [Related]  

  • 12. [Biochemical aspects of human behaviour (author's transl)].
    Ambrozi L; Birkmayer W; Danielczyk W; Neumayer E; Riederer P
    Folia Clin Int (Barc); 1973 Sep; 23(9):565-87. PubMed ID: 4616856
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug treatment of diseases characterized by abnormal movements.
    Marsden CD
    Proc R Soc Med; 1973 Sep; 66(9):871-3. PubMed ID: 4281483
    [No Abstract]   [Full Text] [Related]  

  • 14. The suppression of involuntary movements with tetrabenazine.
    McLellan DL
    Scott Med J; 1972 Nov; 17(11):367-70. PubMed ID: 4264428
    [No Abstract]   [Full Text] [Related]  

  • 15. [Changes in the electroencephalogram during treatment with amantadine].
    Ferro-Milone F; Parisen-Toldin P
    Minerva Med; 1971 Oct; 62(82):4004-6. PubMed ID: 5125064
    [No Abstract]   [Full Text] [Related]  

  • 16. Physostigmine in choreiform movement disorders.
    Tarsy D; Leopold N; Sax DS
    Neurology; 1974 Jan; 24(1):28-33. PubMed ID: 4358998
    [No Abstract]   [Full Text] [Related]  

  • 17. The treatment of the choreas and athetotic dystonias.
    Godwin-Austen RB
    J R Coll Physicians Lond; 1979 Jan; 13(1):35-8. PubMed ID: 368331
    [No Abstract]   [Full Text] [Related]  

  • 18. [Monoamines and choreic syndromes].
    Constantinidis J
    Rev Neurol (Paris); 1972 Jul; 127(1):65-77. PubMed ID: 4272133
    [No Abstract]   [Full Text] [Related]  

  • 19. Phenytoin plasma concentrations in paroxysmal kinesigenic choreoathetosis.
    Homan RW; Vasko MR; Blaw M
    Neurology; 1980 Jun; 30(6):673-6. PubMed ID: 7189844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Observations on the range of efficacy of L-dopa.
    Klawans HL
    Confin Neurol; 1971; 33(3):133-45. PubMed ID: 4940610
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.